Results 261 to 270 of about 912,101 (303)
Some of the next articles are maybe not open access.
The Lancet, 2023
Hepatitis C virus (HCV) is a hepatotropic RNA virus that can cause acute and chronic hepatitis, with progressive liver damage resulting in cirrhosis, decompensated liver disease, and hepatocellular carcinoma. In 2016, WHO called for the elimination of HCV infection as a public health threat by 2030. Despite some progress, an estimated 57 million people
Marianne, Martinello +3 more
openaire +2 more sources
Hepatitis C virus (HCV) is a hepatotropic RNA virus that can cause acute and chronic hepatitis, with progressive liver damage resulting in cirrhosis, decompensated liver disease, and hepatocellular carcinoma. In 2016, WHO called for the elimination of HCV infection as a public health threat by 2030. Despite some progress, an estimated 57 million people
Marianne, Martinello +3 more
openaire +2 more sources
Journal of the American Academy of Nurse Practitioners, 1999
Hepatitis C virus infection is responsible for significant morbidity and mortality worldwide. Advances in detection and monitoring of hepatitis C virus infection, as well as treatment protocols, have contributed to the medical focus on this high profile disease.
Tina Loayza, Lorna Schumann
openaire +4 more sources
Hepatitis C virus infection is responsible for significant morbidity and mortality worldwide. Advances in detection and monitoring of hepatitis C virus infection, as well as treatment protocols, have contributed to the medical focus on this high profile disease.
Tina Loayza, Lorna Schumann
openaire +4 more sources
The Lancet, 2019
Hepatitis C is a global health problem, and an estimated 71·1 million individuals are chronically infected with hepatitis C virus (HCV). The global incidence of HCV was 23·7 cases per 100 000 population (95% uncertainty interval 21·3-28·7) in 2015, with an estimated 1·75 million new HCV infections diagnosed in 2015. Globally, the most common infections
C Wendy, Spearman +3 more
openaire +2 more sources
Hepatitis C is a global health problem, and an estimated 71·1 million individuals are chronically infected with hepatitis C virus (HCV). The global incidence of HCV was 23·7 cases per 100 000 population (95% uncertainty interval 21·3-28·7) in 2015, with an estimated 1·75 million new HCV infections diagnosed in 2015. Globally, the most common infections
C Wendy, Spearman +3 more
openaire +2 more sources
Therapeutische Umschau, 2004
Die Infektion mit dem Hepatitis C Virus (HCV) ist weltweit eine der häufigsten Ursachen der chronischen Hepatitis, Leberzirrhose und des hepatozellulären Karzinoms. In diesem Beitrag werden der aktuelle Stand und neue Entwicklungen auf dem Gebiet der Virologie, Diagnostik und Therapie der Hepatitis C zusammenfassend dargestellt.
D, Moradpour, H E, Blum
openaire +2 more sources
Die Infektion mit dem Hepatitis C Virus (HCV) ist weltweit eine der häufigsten Ursachen der chronischen Hepatitis, Leberzirrhose und des hepatozellulären Karzinoms. In diesem Beitrag werden der aktuelle Stand und neue Entwicklungen auf dem Gebiet der Virologie, Diagnostik und Therapie der Hepatitis C zusammenfassend dargestellt.
D, Moradpour, H E, Blum
openaire +2 more sources
Current Opinion in Hematology, 2000
Hepatitis C was responsible for the majority of cases of posttransfusion hepatitis before the introduction of a specific screening test for blood donors. Infected recipients may remain asymptomatic for many years, but cirrhosis and hepatocellular carcinoma may develop decades after infection. Lookback, or the identification of recipients of potentially
M, Goldman, G, Spurll
openaire +2 more sources
Hepatitis C was responsible for the majority of cases of posttransfusion hepatitis before the introduction of a specific screening test for blood donors. Infected recipients may remain asymptomatic for many years, but cirrhosis and hepatocellular carcinoma may develop decades after infection. Lookback, or the identification of recipients of potentially
M, Goldman, G, Spurll
openaire +2 more sources
The Lancet, 2003
More than 170 million people worldwide are chronically infected with the hepatitis C virus (HCV), which is responsible for more than 100000 cases of liver cancer per year, with similar numbers of digestive haemorrhage and ascites episodes. Major breakthroughs have been made in diagnosis and treatment, and advances in molecular biology mean that the ...
Yuen, MF +3 more
openaire +4 more sources
More than 170 million people worldwide are chronically infected with the hepatitis C virus (HCV), which is responsible for more than 100000 cases of liver cancer per year, with similar numbers of digestive haemorrhage and ascites episodes. Major breakthroughs have been made in diagnosis and treatment, and advances in molecular biology mean that the ...
Yuen, MF +3 more
openaire +4 more sources
The Lancet, 2008
Symptomatic acute hepatitis C occurs in only about 15% of patients who are infected with hepatitis C virus (HCV). Acute hepatitis C is most often diagnosed in the setting of post-exposure surveillance, or seroconversion in high-risk individuals (eg, health-care professionals or injecting drug users) previously known to be seronegative.
Anurag, Maheshwari +2 more
openaire +2 more sources
Symptomatic acute hepatitis C occurs in only about 15% of patients who are infected with hepatitis C virus (HCV). Acute hepatitis C is most often diagnosed in the setting of post-exposure surveillance, or seroconversion in high-risk individuals (eg, health-care professionals or injecting drug users) previously known to be seronegative.
Anurag, Maheshwari +2 more
openaire +2 more sources
Seminars in Liver Disease, 2009
Hepatitis C virus (HCV) is a leading cause of end-stage liver disease worldwide and the most common indication for liver transplantation in the United States and Europe. HCV nearly always recurs in liver-transplanted patients, and 10 to 25% of them develop cirrhosis within 5 to 10 years.
openaire +2 more sources
Hepatitis C virus (HCV) is a leading cause of end-stage liver disease worldwide and the most common indication for liver transplantation in the United States and Europe. HCV nearly always recurs in liver-transplanted patients, and 10 to 25% of them develop cirrhosis within 5 to 10 years.
openaire +2 more sources